MODALITY
saveCAR-T
T cells engineered with chimeric antigen receptors.
also known as: cart, chimeric antigen receptor t-cell
🐶 often sniffed alongside
top 8- tagUrology27 co-mentions · 1 sources
- tagRecall14 co-mentions · 7 sources
- tagHepatology12 co-mentions · 1 sources
- tagNeurology10 co-mentions · 2 sources
- tagOncology9 co-mentions · 4 sources
- tagNephrology9 co-mentions · 1 sources
- tagOphthalmology6 co-mentions · 2 sources
- tagEndocrinology & Metabolism3 co-mentions · 1 sources
drugs
0
catalysts
0
news
427
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Weighing the risks of CAR T in autoimmune disease as Kyverna nears marketbiospace · 6h ago
- Novartis wagers almost $8B on a Chinese biotech’s RNA drugsbiopharma dive · 2d ago
- Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engagerfiercebiotech · 3d ago
- Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEOfiercebiotech · 3d ago
- Trump administration appeals ruling blocking limits on international student visasstat · 3d ago
- AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a rollbiospace · 5d ago
- STAT+: AstraZeneca invests $2 billion in Summit Therapeuticsstat · 5d ago
- Spark co-founder Steven Altschuler is back with an immune-resetting biotechendpoints · 5d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that